Actively Recruiting
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-31
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the outcomes for pregnant women experiencing genital bleeding after the 18th week of pregnancy. The study focuses on important maternal and fetal events such as premature birth, maternal-fetal bleeding, and maternal or neonatal death. It also investigates how well ultrasound techniques identify the causes of these bleedings, which might help tailor individual pregnancy care more accurately. Participants will not have special study visits. Instead, data collected during their regular pregnancy care and delivery at the study center will be analyzed. The study observes the natural course of pregnancies complicated by genital bleeding beyond 18 weeks, including hospitalization rates, delivery methods, treatments for bleeding, and newborn health measures. During the study, researchers will review medical records for hospital stay length, ultrasound findings at admission, birth outcomes such as birth weight and Apgar scores, and any therapies used for bleeding. This observational approach allows monitoring of real-world pregnancy outcomes up to 24 weeks after delivery. The total participation involves the usual prenatal and delivery care without additional interventions.
CONDITIONS
Brief Title
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnancy beyond 18 weeks gestational age complicated by genital bleeding
- Age of the patient 60 years
- Delivery at the Obstetrics and Prenatal Age Medicine Unit
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
No study-specific visits are planned; data are collected during routine pregnancy and delivery care.
Duration - At time of admission for bleeding
Participants undergo obstetric ultrasounds to identify the cause of genital bleeding beyond 18 weeks of pregnancy.
1 visit (routine ultrasound at admission)
Duration - From admission through delivery and up to 24 weeks postpartum
Participants are observed through pregnancy and delivery to evaluate maternal and fetal outcomes related to genital bleeding.
Data collected during routine prenatal visits and delivery; no additional study visits
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
E
Elisa Montaguti, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here